The epidemiology of Candida fungal infections is growing, due to the increasing size of the people at risk. Candida species are the fourth main cause of bloodstream infections; however, significant geographic differences have been reported. Although, in some instances, these changes may be related to medical interventions, such as the use of antifungal agents in prophylaxis, in the majority of cases, they seem to be a consequence of changes in the host, such as more-severe immunosuppression or different types of immunosuppression impacting both risk periods and the infections that occur.Discussion of surveillances and reports will be critical to improve our understanding of the importance of invasive Candida infections, and to facilitate the prioritization of the investigation as well as the prevention efforts.